The study to evaluate the efficacy and resistance for EGFR-TKIs treatment in lung cancer patients.
Not Applicable
- Conditions
- lung cancer
- Registration Number
- JPRN-UMIN000002193
- Lead Sponsor
- Second Department of Internal Medicine, Nagasaki University hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
except for the above-mentioned
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method corrlation of genomic profile and efficacy and resistance
- Secondary Outcome Measures
Name Time Method adverse ivent, survival, patinets characteristics